https://zasocitinibinhibitor.c....om/molecular-amazing
The study is designed to comply with the standards of the Declaration of Helsinki and the stipulations of Japan's Clinical Trials Act. The Certified Review Board of National Cancer Center Hospital East (reference K2021004) has given its approval for the study protocol. At https://jrct.niph.go.jp/en-lat....est-detail/jRCTs0312 one can find the November 2021, version 30 registratio
Like
Comment
Share
